On the advice of a friend, he enrolled Prince in a clinical trial at Colorado State University’s Flint Animal Cancer Center, where researchers were testing a subcutaneous delivery method for Interleukin 12, a powerful immune enhancer that is also under study for treating advanced cancers in people.

link